BOOM
Recent additions may not be included but will usually appear in 24 hrs or less.
| Rational | Source |
|---|---|
|
Comparison of populations of human faecal bacteria before and after in vitro incubation with plant cell wall substrates. ✅
The Journal of applied bacteriology (J Appl Bacteriol ) Vol: 62 Issue 3 Pages: 231-40 Pub: 1987 Mar Epub: Authors Slade AP , Wyatt GM , Bayliss CE , Waites WM , |
|
|
Xylan utilization in human gut commensal bacteria is orchestrated by unique modular organization of polysaccharide-degrading enzymes. ✅
Go to Publication ✅
Proceedings of the National Academy of Sciences of the United States of America (Proc Natl Acad Sci U S A ) Vol: 111 Issue 35 Pages: E3708-17 Pub: 2014 Sep 2 Epub: 2014 Aug 18 Authors Zhang M , Chekan JR , Dodd D , Hong PY , Radlinski L , Revindran V , Nair SK , Mackie RI , Cann I , |
|
|
Xylan utilization in human gut commensal bacteria is orchestrated by unique modular organization of polysaccharide-degrading enzymes. ✅
Go to Publication ✅
Proceedings of the National Academy of Sciences of the United States of America (Proc Natl Acad Sci U S A ) Vol: 111 Issue 35 Pages: E3708-17 Pub: 2014 Sep 2 Epub: 2014 Aug 18 Authors Zhang M , Chekan JR , Dodd D , Hong PY , Radlinski L , Revindran V , Nair SK , Mackie RI , Cann I , |
|
|
The role of short-chain fatty acids in microbiota-gut-brain communication. ✅
Go to Publication ✅
Nature reviews. Gastroenterology & hepatology (Nat Rev Gastroenterol Hepatol ) Vol: 16 Issue 8 Pages: 461-478 Pub: 2019 Aug Epub: Authors Dalile B , Van Oudenhove L , Vervliet B , Verbeke K , |
|
|
The role of short-chain fatty acids in microbiota-gut-brain communication. ✅
Go to Publication ✅
Nature reviews. Gastroenterology & hepatology (Nat Rev Gastroenterol Hepatol ) Vol: 16 Issue 8 Pages: 461-478 Pub: 2019 Aug Epub: Authors Dalile B , Van Oudenhove L , Vervliet B , Verbeke K , |
|
|
Targeted modification of gut microbiota and related metabolites via dietary fiber. ✅
Go to Publication ✅
Carbohydrate polymers (Carbohydr Polym ) Vol: 316 Issue Pages: 120986 Pub: 2023 Sep 15 Epub: 2023 May 16 Authors Nie Q , Sun Y , Li M , Zuo S , Chen C , Lin Q , Nie S , |
|
|
Targeted modification of gut microbiota and related metabolites via dietary fiber. ✅
Go to Publication ✅
Carbohydrate polymers (Carbohydr Polym ) Vol: 316 Issue Pages: 120986 Pub: 2023 Sep 15 Epub: 2023 May 16 Authors Nie Q , Sun Y , Li M , Zuo S , Chen C , Lin Q , Nie S , |
|
|
The Effect of Xylooligosaccharide, Xylan, and Whole Wheat Bran on the Human Gut Bacteria. ✅
Go to Publication ✅
Frontiers in microbiology (Front Microbiol ) Vol: 11 Issue Pages: 568457 Pub: 2020 Epub: 2020 Dec 3 Authors Chen M , Liu S , Imam KMSU , Sun L , Wang Y , Gu T , Wen B , Xin F , |
BOOM
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
